{{Rsnum
|rsid=6805251
|Gene=GSK3B
|Chromosome=3
|position=119841759
|Orientation=plus
|GMAF=0.4449
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GSK3B
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 42.7 | 48.2 | 9.1
| HCB | 21.3 | 55.9 | 22.8
| JPT | 20.7 | 45.9 | 33.3
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 22.8 | 77.2
| CHB | 21.3 | 55.9 | 22.8
| CHD | 17.6 | 50.9 | 31.5
| GIH | 24.8 | 47.5 | 27.7
| LWK | 0.0 | 8.2 | 91.8
| MEX | 38.9 | 51.9 | 9.3
| MKK | 3.2 | 28.8 | 67.9
| TSI | 28.7 | 57.4 | 13.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=20605420
|Title=Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians
}}

{{PMID Auto
|PMID=17270183
|Title=Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome.
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}